abstract |
The present invention relates to novel compounds having general formula (I) and useful as selective ER-β ligands in the treatment or prevention of Alzheimer's disease, anxiety, depression, osteoporosis, cardiovascular disease, rheumatoid arthritis or prostate cancer. |